These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Monoclonal antibodies against beta nerve growth factor and their effects on receptor binding and biological activity. Zimmermann A, Sutter A, Shooter EM. Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4611-5. PubMed ID: 6270686 [Abstract] [Full Text] [Related]
3. Two distinct monoclonal antibodies raised against mouse beta nerve growth factor. Generation of bi-specific anti-nerve growth factor anti-horseradish peroxidase antibodies for use in a homogeneous enzyme immunoassay. Kenigsberg RL, Elliott PJ, Cuello AC. J Immunol Methods; 1991 Feb 15; 136(2):247-57. PubMed ID: 1999653 [Abstract] [Full Text] [Related]
4. Immunological determinants of nerve growth factor involved in p140trk (Trk) receptor binding. Nanduri J, Vroegop SM, Buxser SE, Neet KE. J Neurosci Res; 1994 Mar 01; 37(4):433-44. PubMed ID: 7517456 [Abstract] [Full Text] [Related]
6. Characterization of ultra-high affinity monoclonal antibodies with a dimeric, symmetrical antigen: inhibition of the receptor recognition site of nerve growth factor. Vroegop SM, Crumm E, Buxser SE. Mol Immunol; 1992 Mar 01; 29(3):411-23. PubMed ID: 1313539 [Abstract] [Full Text] [Related]
7. Monoclonal antibodies to the cell surface and a soluble form of the human nerve growth factor receptor. Clagett-Dame M, Chung C, Chao MV, DiStefano PS. J Neurosci Res; 1990 Dec 01; 27(4):642-50. PubMed ID: 1706784 [Abstract] [Full Text] [Related]
9. Biochemical, immunocytochemical and morphological evidence for an interaction between thyroid hormone and nerve growth factor in the developing cerebellum of normal and hypothyroid rats. Legrand C, Clos J. Dev Neurosci; 1991 Dec 01; 13(6):382-96. PubMed ID: 1667097 [Abstract] [Full Text] [Related]
12. Selective destruction of nerve growth factor receptor-bearing cells in vitro using a hybrid toxin composed of ricin A chain and a monoclonal antibody against the nerve growth factor receptor. DiStefano PS, Schweitzer JB, Taniuchi M, Johnson EM. J Cell Biol; 1985 Sep 01; 101(3):1107-14. PubMed ID: 2993314 [Abstract] [Full Text] [Related]
14. Evidence that biological activity of NGF is mediated through a novel subclass of high affinity receptors. Weskamp G, Reichardt LF. Neuron; 1991 Apr 01; 6(4):649-63. PubMed ID: 1849725 [Abstract] [Full Text] [Related]
15. Characterization of functional nerve growth factor-receptors in a CNS glial cell line: monoclonal antibody 217c recognizes the nerve growth factor-receptor on C6 glioma cells. Kumar S, Huber J, Peña LA, Perez-Polo JR, Werrbach-Perez K, de Vellis J. J Neurosci Res; 1990 Nov 01; 27(3):408-17. PubMed ID: 1965839 [Abstract] [Full Text] [Related]
16. Characterization of the binding properties and retrograde axonal transport of a monoclonal antibody directed against the rat nerve growth factor receptor. Taniuchi M, Johnson EM. J Cell Biol; 1985 Sep 01; 101(3):1100-6. PubMed ID: 2411735 [Abstract] [Full Text] [Related]
17. Production of a monoclonal antibody directed against the nerve growth factor receptor from sympathetic membranes. Morgan CJ, Bradshaw RA. J Cell Biochem; 1985 Sep 01; 27(2):121-32. PubMed ID: 2985634 [Abstract] [Full Text] [Related]